. Author manuscript; available in PMC: 2020 Dec 15.

Published in final edited form as: Am J Cardiol. 2019 Dec 26;125(6):988–996. doi: 10.1016/j.amjcard.2019.12.019

Table 5.

Cardiac-specific blood-based biomarkers

Biomarker	Abnormal response	Values
N-terminal pro-brain natriuretic peptide (pg/ml)	14 (56%)	180 (47–344)
High-sensitivity C-reactive protein (mg/L)	16 (64%)	3.0 (1.7–6.9)
Galectin-3 (ng/ml)	8 (32 %)	15.4 (12.8–19.8)
High-sensitivity cardiac troponin T (ng/L)	5 (20%)	9.5 (5.1–13.8)
High-sensitivity cardiac troponin I (ng/L)	3 (12%)	4.0 (2.0–8.0)
Soluble suppression of tumorigenicity-2 (ST2; [ng/ml])	8 (32%)	28.2 (21.9–37.3)

Data are listed as n (%) or median and (interquartile range). Abnormal response was defined as: N-terminal pro-brain natriuretic peptide ≥125 pg/ml, high-sensitivity C-reactive protein ≥2 mg/L, Galectin-3 >17.8 ng/ml, high-sensitivity cardiac troponin T (Male >22 ng/L, Female >14 ng/L), high-sensitivity cardiac troponin I (Male >14 ng/L, Female >11.1 ng/L), soluble suppression of tumorigenicity-2 ≥35 ng/ml. pg/ml = picograms per milliliter; mg/L = milligrams per liter; ng/L = nanograms per liter; ng/ml = nanograms per milliliter.